Mazdutide vs Tirzepatide

Mazdutide is an experimental GLP-1 and glucagon dual-receptor drug still in development, with no FDA approvals yet. Tirzepatide, sold as Mounjaro or Zepbound, is an approved GIP and GLP-1 dual-receptor drug used to treat type 2 diabetes, obesity, and obstructive sleep apnea. The main practical difference is that Mazdutide is not yet available for use, while Tirzepatide is already on the market under two brand names.

AI summary of the sources below.